Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TYRO3P is classified as a *pseudogene* by HUGO Gene Nomenclature Committee (HGNC), Ensembl, and NCBI, and does not encode a functional protein[1][2][7][8]. It is related in sequence to the TYRO3 receptor tyrosine kinase gene, but distinctively lacks coding potential and is not implicated in known signaling, disease, or drug mechanism contexts[7][8]. There are no validated biological functions, disease roles, molecular interactions, or therapeutic relevance associated with TYRO3P. The functional, protein-coding gene in the family is **TYRO3 protein tyrosine kinase** (abbreviation TYRO3), which is a true receptor tyrosine kinase involved in important signaling processes, cell proliferation, and immune regulation, and is considered a therapeutic target in various diseases[3][6]. However, TYRO3P itself is strictly classified as a *pseudogene*, not an active target or biomarker[1][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TYRO3 protein tyrosine kinase pseudogene (TYRO3P).